[First Quarter 2022 Financial Results](index=2&type=section&id=First%20Quarter%202022%20Financial%20Results) This section provides a comprehensive overview of Materialise's financial performance for the first quarter of 2022, including key financial metrics, segment-specific results, consolidated financial statements, and non-IFRS reconciliations [Overall Financial Highlights](index=2&type=section&id=Overall%20Financial%20Highlights) Materialise reported a 16.3% increase in total revenue to **€53.0 million** for the first quarter of 2022. The company achieved a net profit of **€127k**, a significant turnaround from a net loss of **€3.6 million** in the prior-year period, primarily driven by a positive net financial result. Adjusted EBITDA saw a slight increase to **€5.4 million**, though the margin decreased to **10.3%**. The company's net cash position decreased, partly due to the acquisition of Link3D Q1 2022 Key Financial Metrics (vs. Q1 2021) | Metric | Q1 2022 (€'000) | Q1 2021 (€'000) | Change | | :--- | :--- | :--- | :--- | | **Total Revenue** | 52,961 | 45,554 | +16.3% | | **Gross Profit** | 28,884 | 24,568 | +17.6% | | **Operating Result** | 49 | 290 | -83.1% | | **Net Profit/(Loss)** | 127 | (3,642) | Turnaround to Profit | | **Adjusted EBITDA** | 5,443 | 5,341 | +1.9% | | **Adjusted EBITDA Margin** | 10.3% | 11.7% | -1.4 p.p. | - Operating expenses (R&D, S&M, G&A) increased by **17.2%** to **€29.8 million**, outpacing revenue growth and contributing to the decline in operating profit[6](index=6&type=chunk) Balance Sheet and Cash Flow Highlights (as of March 31, 2022) | Metric | March 31, 2022 (€'000) | Dec 31, 2021 (€'000) | Change | | :--- | :--- | :--- | :--- | | **Cash & Cash Equivalents** | 169,610 | 196,028 | -€26,418k | | **Gross Debt** | 93,583 | 99,107 | -€5,524k | | **Net Cash Position** | 76,027 | 96,921 | -€20,894k | | **Cash Flow from Operations (Q1)** | 11,111 | 4,231 (Q1 2021) | +162.6% | - The decrease in the net cash position was influenced by the exercise of the call option to acquire **100%** of the shares of Link3D[11](index=11&type=chunk) [Segment Performance](index=2&type=section&id=Segment%20Performance) All three business segments reported revenue growth in Q1 2022. Materialise Manufacturing led with a **26.2%** increase, followed by Medical at **13.0%** and Software at **2.6%**. The Manufacturing segment also showed a significant turnaround in profitability, with its Adjusted EBITDA margin growing to **10.8%** from **-0.8%** YoY. In contrast, both the Software and Medical segments experienced a decline in their Adjusted EBITDA margins, with Software's results impacted by investments in the newly consolidated Link3D Q1 2022 Revenue by Segment (vs. Q1 2021) | Segment | Q1 2022 Revenue (€'000) | Q1 2021 Revenue (€'000) | YoY Growth | | :--- | :--- | :--- | :--- | | **Materialise Manufacturing** | 24,131 | 19,114 | +26.2% | | **Materialise Medical** | 18,347 | 16,231 | +13.0% | | **Materialise Software** | 10,483 | 10,219 | +2.6% | Q1 2022 Adjusted EBITDA by Segment (vs. Q1 2021) | Segment | Q1 2022 Adj. EBITDA (€'000) | Q1 2021 Adj. EBITDA (€'000) | Margin (Q1 2022) | Margin (Q1 2021) | | :--- | :--- | :--- | :--- | :--- | | **Materialise Medical** | 3,227 | 4,541 | 17.6% | 28.0% | | **Materialise Manufacturing** | 2,613 | (144) | 10.8% | (0.8)% | | **Materialise Software** | 1,932 | 3,429 | 18.4% | 33.6% | - The results of Link3D have been fully consolidated within the Materialise Software segment starting from the beginning of 2022[4](index=4&type=chunk) [Consolidated Financial Statements](index=4&type=section&id=Consolidated%20Financial%20Statements) This section presents the unaudited consolidated financial statements for the three months ended March 31, 2022, including the income statement, statement of comprehensive income, statement of financial position, and statement of cash flows. The statements show a return to net profitability, stable total assets, and a significant increase in cash flow from operating activities compared to the prior-year period [Consolidated Income Statement](index=4&type=section&id=Consolidated%20Income%20Statement) This statement details the company's revenues, expenses, and net profit or loss for the first quarter of 2022, showing a return to profitability Q1 2022 Income Statement Highlights (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Revenue** | 52,961 | 45,554 | | **Gross Profit** | 28,884 | 24,568 | | **Operating Profit** | 49 | 290 | | **Profit (Loss) before taxes** | 425 | (3,822) | | **Net Profit (Loss) for the period** | 127 | (3,642) | | **Basic EPS (€)** | 0.00 | (0.07) | [Consolidated Statement of Comprehensive Income](index=5&type=section&id=Consolidated%20Statement%20of%20Comprehensive%20Income) This statement presents the net profit or loss along with other comprehensive income items, reflecting the total change in equity from non-owner sources Q1 2022 Comprehensive Income (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Net profit (loss) for the period** | 127 | (3,642) | | **Other comprehensive income, net of taxes** | 1,416 | 492 | | **Total comprehensive income (loss)** | 1,543 | (3,150) | [Consolidated Statement of Financial Position](index=6&type=section&id=Consolidated%20Statement%20of%20Financial%20Position) This statement provides a snapshot of the company's assets, liabilities, and equity as of March 31, 2022, indicating a stable financial structure Financial Position Highlights (Unaudited) | In '000 € | March 31, 2022 | Dec 31, 2021 | | :--- | :--- | :--- | | **Total Non-current assets** | 185,040 | 155,605 | | **Total Current assets** | 229,074 | 257,803 | | **Total Assets** | 414,115 | 413,408 | | **Total Equity** | 234,115 | 232,578 | | **Total Liabilities** | 179,994 | 180,830 | [Consolidated Statement of Cash Flows](index=8&type=section&id=Consolidated%20Statement%20of%20Cash%20Flows) This statement summarizes the cash inflows and outflows from operating, investing, and financing activities for the first quarter of 2022 Q1 2022 Cash Flow Summary (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Net cash flow from operating activities** | 11,111 | 4,231 | | **Net cash flow used in investing activities** | (30,820) | (2,949) | | **Net cash flow from (used in) financing activities** | (7,452) | (5,384) | | **Net decrease of cash & cash equivalents** | (27,161) | (4,102) | - Investing activities included a significant cash outflow of **€27.4 million** for the acquisition of a subsidiary (Link3D), which was the primary driver of the net decrease in cash[27](index=27&type=chunk) [Non-IFRS Measures and Reconciliations](index=3&type=section&id=Non-IFRS%20Measures%20and%20Reconciliations) This section details the company's use of non-IFRS measures, specifically EBITDA and Adjusted EBITDA, which management believes are important for evaluating operational performance by excluding long-term investment and financing decisions. It provides reconciliations from IFRS net profit to both consolidated Adjusted EBITDA and segment-level Adjusted EBITDA - Management uses EBITDA and Adjusted EBITDA as supplemental measures to assess the performance of day-to-day operations and the company's ability to grow[16](index=16&type=chunk) - Adjusted EBITDA is calculated by adding back share-based compensation, acquisition-related expenses, impairments, and revaluations to EBITDA[16](index=16&type=chunk) [Reconciliation to EBITDA and Adjusted EBITDA](index=10&type=section&id=Reconciliation%20to%20EBITDA%20and%20Adjusted%20EBITDA) This reconciliation details the adjustments made from net profit to derive EBITDA and Adjusted EBITDA, providing a clearer view of core operational profitability Q1 2022 Reconciliation to Adjusted EBITDA (Unaudited) | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Net profit (loss) for the period** | 127 | (3,642) | | Income taxes | 298 | (181) | | Financial expenses | 1,289 | 4,701 | | Financial income | (1,665) | (589) | | Depreciation and amortization | 5,442 | 5,081 | | **EBITDA** | **5,491** | **5,371** | | Share-based compensation expense | (48) | (415) | | Acquisition-related expenses | — | 385 | | **Adjusted EBITDA** | **5,443** | **5,341** | [Segment P&L and Reconciliation](index=11&type=section&id=Segment%20P%26L%20and%20Reconciliation) This section provides a breakdown of segment-level revenues and Adjusted EBITDA, along with a reconciliation from operating profit to total segment Adjusted EBITDA Q1 2022 Segment Adjusted EBITDA (Unaudited) | In '000 € | Software | Medical | Manufacturing | Total Segments | Unallocated | Consolidated | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **Revenues** | 10,483 | 18,347 | 24,131 | 52,961 | 0 | 52,961 | | **Segment (adj) EBITDA** | 1,932 | 3,227 | 2,613 | 7,772 | (2,329) | 5,443 | | **Segment (adj) EBITDA %** | 18.4% | 17.6% | 10.8% | 14.7% | N/A | 10.3% | Reconciliation from Operating Profit to Segment Adjusted EBITDA | In '000 € | Q1 2022 | Q1 2021 | | :--- | :--- | :--- | | **Operating profit** | 49 | 289 | | Depreciation and amortization | 5,442 | 5,081 | | Corporate R&D | 816 | 692 | | Corporate headquarter costs | 2,106 | 2,648 | | Other operating income (expense) | (640) | (855) | | **Segment adjusted EBITDA** | **7,772** | **7,855** |

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

Materialise NV (NASDAQ:MTLS) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Harriet Fried - IR Peter Leys - Executive Chairman Johan Albrecht - EVP & CFO Wilfried Vancraen - Founder, CEO & Director Conference Call Participants Jacob Stephan - Lake Street Capital Noelle Dilts - Stifel, Nicolaus & Company Gregory Ramirez - Bryan Garnier & Co Ltd Jason Celino - KeyBanc Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q1 2022 Materialise Financial ...

materialise innovators you can count on Q1 2022 Financial Results Conference Call April 28, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and pros ...

Materialise NV (NASDAQ:MTLS) Q4 2021 Earnings Conference Call March 3, 2022 8:30 AM ET Company Participants Fried Vancraen ??? Founder and Chief Executive Officer Johan Albrecht ??? Chief Financial Officer Peter Leys ??? Executive Chairman Harriet Fried ??? Investor Relations Conference Call Participants Troy Jensen ??? Lake Street Capital Devin Au ??? KeyBanc Capital Markets Noelle Dilts ??? Stifel Gregory Ramirez ??? Bryan Garnier Bhavna Advani ??? JPMorgan Operator Good day. Thank you for standing ...

materialise innovators you can count on Q4 2021 Financial Results Conference Call March 3, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prosp ...

Financial Data and Key Metrics Changes - Materialise reported a record quarterly revenue of EUR52.2 million, representing a 28% increase year-over-year [8][17] - Adjusted EBITDA reached EUR9.739 million, a 62% increase compared to the previous year, with an EBITDA margin of almost 19% [8][18] - Net profit for the quarter was EUR8.652 million, or EUR0.15 per diluted share, compared to a net loss of EUR282,000 in the same period last year [23] Business Line Data and Key Metrics Changes - Software segment revenue increased by 10.4% to EUR10.468 million, with an adjusted EBITDA margin of 35.4% [18][19] - Medical segment revenue grew by 10.2% to EUR18.9 million, with adjusted EBITDA of EUR5.251 million, maintaining a margin of 31.8% [19][20] - Manufacturing segment revenue surged by 61.2% to EUR22.8 million, with an adjusted EBITDA margin of 15.5% [21][22] Market Data and Key Metrics Changes - The automotive market remains unstable due to supply chain disruptions, affecting both European and global operations [29] - The airliner market continues to show weakness, impacting revenue from plastic automotive prototyping [12][29] - Other segments, such as wearables and medical instrumentation, are experiencing growth, offsetting declines in automotive and aerospace [12] Company Strategy and Development Direction - Materialise focuses on meaningful applications in additive manufacturing, aiming to create value for customers while ensuring sustainable growth [11][16] - The company is committed to reducing its carbon footprint, targeting a 50% reduction by 2025, with a 33% reduction achieved by the end of 2021 [16] - Investments are being made in growth initiatives, including CMS, footwear, and eyewear, with expectations for continued growth in these areas [36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue closer to the higher end of the EUR197 million to EUR200 million range for 2021 [26] - The company plans to gradually increase operational expenses to support growth initiatives, impacting 2022 results more significantly [26] - Management remains cautious about economic uncertainties but believes in the strength of their product offerings and market recovery [33] Other Important Information - The company reported a strong balance sheet with cash amounting to EUR194.9 million, up from EUR111.5 million at the end of the previous year [24] - Deferred revenue totaled EUR35 million, primarily related to annual software sales and maintenance contracts [25] Q&A Session Summary Question: Signs of improvement in the automotive market? - Management noted ongoing instability in the automotive market due to supply chain disruptions, with expectations for this to continue throughout the year [29] Question: Growth drivers in the medical segment? - The growth in the medical segment is attributed to structural growth rather than pent-up demand, with software sales increasing by 15% [30] Question: Clarification on guidance and economic uncertainty? - Management acknowledged economic uncertainty but emphasized their historical approach to providing annual guidance, balancing strong quarterly performance with realistic expectations [33] Question: Update on strategic priorities and investments? - Growth has been reported in CMS, footwear, and eyewear, with significant investments planned for the footwear segment to ensure long-term growth [36] Question: Sustainability of manufacturing margins? - Management indicated that while current margins are strong, manufacturing is a cyclic business, and they prefer to focus on high-end applications rather than overinvesting in capacity [53]

Financial Performance - Q3 2021 revenue increased by 28% year-over-year to 52195 kEUR[6,11] - Q3 2021 Adjusted EBITDA increased by 62% year-over-year to 9739 kEUR[6,15] - Adjusted EBITDA margin increased to 18.7% in Q3 2021[6,15] - Q3 2021 Net result grew to 8652 kEUR, compared to a loss of (282) kEUR in Q3 2020[6] - Earnings per share reached 0.15 EUR-ct in Q3 2021[6] Segment Performance - Materialise Manufacturing revenue rose 61% compared to Q3 2020[13] - Software segment revenue increased by 10.4% year-over-year to 10468 kEUR in Q3 2021[18] - Medical segment revenue rose by 10.2% to 18910 kEUR in Q3 2021[20] - Manufacturing segment revenue increased by 61.2% year-over-year to 22817 kEUR in Q3 2021[23] Financial Position - Cash and equivalents increased to 194946 kEUR as of September 30, 2021, compared to 111538 kEUR at the end of 2020[25] Outlook - The company expects revenue to be at the higher end of the 197 million EUR - 200 million EUR range for 2021[27] - The company is increasing its Adjusted EBITDA guidance by 3 million EUR to up to 28 million EUR for 2021[27]

Financial Data and Key Metrics Changes - Revenues grew 33% to EUR 50.7 million compared to the same period last year, with adjusted EBITDA more than doubling to EUR 6.9 million [9][27] - Compared to Q1 2021, revenues increased by 11.3% and adjusted EBITDA rose by 13% [11] - Compared to Q2 2019, revenues grew by 5% and adjusted EBITDA increased by 37% [12] Business Line Data and Key Metrics Changes - Software segment revenue increased by 5% to EUR 10 million, with a 24% increase in recurrent sales [32] - Medical segment revenue surged over 50% to EUR 17.5 million, with a 21% growth compared to Q2 2019 [34] - Manufacturing segment revenue increased by 39% to EUR 23.3 million, recovering 22% from Q1 2021 [36] Market Data and Key Metrics Changes - The Medical segment accounted for 34% of total revenue, while Manufacturing represented 46% [29] - Deferred revenues from software licenses and maintenance fees increased by EUR 1.7 million compared to the end of last year [28] Company Strategy and Development Direction - The company plans to use newly raised funds to accelerate growth drivers, including the rollout of Magics and Mimics software platforms and expansion in CMF markets [13][14] - The focus remains on 3D printing applications, with no intention to significantly broaden into CNC machining or other conventional manufacturing technologies [64] Management's Comments on Operating Environment and Future Outlook - Management sees a positive but fragile global trend of businesses recovering from the pandemic, expecting revenues for 2021 to exceed 2019 levels, potentially reaching close to EUR 200 million [47][48] - The majority of revenues in the second half of the year are expected to come from a strong fourth quarter [48] Other Important Information - The company moved into a new Metal 3D Printing center in Bremen, Germany, with an official opening planned for October 7th [23] - Cash amounted to EUR 182.8 million at the end of Q2 2021, up from EUR 111.5 million at the end of the previous year [43] Q&A Session Summary Question: How did the recovery in end markets develop through the quarter? - Management noted a positive trend throughout the quarter, with continuous increases in sales in Medical and Software, while the Automotive market remains unstable due to supply chain issues [53] Question: Can the Manufacturing segment exceed 2019 levels? - Management expects Manufacturing to recover but does not anticipate the same revenue mix as in 2019, with Software and Medical becoming more significant parts of overall revenues [55] Question: Thoughts on digital manufacturing and competition? - The company remains focused on 3D printing applications and does not plan to expand significantly into CNC machining or other conventional manufacturing technologies [64] Question: Concerns about new entrants in software competition? - Management respects competition but believes new players face significant hurdles and that the company has a solid base to withstand competitive pressures [67] Question: Expectations for Q3? - Management indicated that Q3 is typically slower, with more growth expected in Q4, aligning with traditional seasonal patterns [69]

materialise innovators you can count on Q2 2021 Financial Results Conference Call July 29, 2021 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prosp ...